INTRODUCTION
============

Polyethylene is a well-known material to orthopaedic surgeons since Sir John Charnley popularized it in his hip LFA (low friction arthroplasty) \[[@R1]\]. The rationale under the use of this polymer has been extensively reviewed \[[@R2]\], with clear advantages over other polymers used in early total hip arthroplasty (THA) designs, such as Teflon (polytetrafluor-ethylene, PTFE) and Delrin (polyacetal). Polyethylene and ultra high molecular weight polyethylene (UHMWPE), became the most popular and standard material in THA friction pairs since the 1960's until the 1990's. Early alternative solutions based on metal-on-metal (MOM) or ceramic-on-ceramic (COC) articulations showed significant pitfalls in many designs \[[@R3],[@R4]\]. The standardized solution of UHMWPE for the acetabulum was at the time inexpensively processed by machining components out of extruded UHMWPE bars, followed by gamma irradiation sterilization of large batchs to doses ranging from 25 to 40 KGy. It is worth observing that UHMWPE is a semicrystalline polymer constituted by a crystalline phase (the crystals, observed in the transmission electron microscopy --TEM- images as lamellae) and an amorphous phase (the disordered state) that allows some rearrangement of the crystals under mechanical stresses \[[@R5]\]. This characteristic semicrystalline structure of UHMWPE is illustrtated in Fig. (**[1](#F1){ref-type="fig"}**). The material had a significantly large molecular weight (ultra-high), meaning long polymer chains that were further reinforced by covalent molecular bridges, also known as cross-links, originated upon gamma irradiation.

In the 1980's and early 1990's, long-term survivorship of polyethylene cups was compromised by osteolysis and aseptic loosening. After significant research, wear particle production was found the triggering mechanism. Cement particles were first considered as the causative agent, the so called "cement disease", but when the osteolysis also prevailed in uncemented designs, polyethylene particles were apparent as the main pathogenetic factor, particularly those in the submicron range. Aseptic loosening and osteolysis resulted in significant concern about polyethylene quality and wear resistance in the Orthopaedic community, and extensive research was devoted to clarify what caused the polyethylene failure and how to prevent it. Unimplanted polyethylene components from the shelf were analyzed to investigate the material prior to *in vivo* use, and subsurface white bands of high density material (Fig. **[2](#F2){ref-type="fig"}**) were found in components with long shelf life \[[@R6],[@R7]\]. Retrieval studies of long-term failures of polyethylene cups showed that polyethylene was not homogeneous. Occasional subsurface white bands and fusion defects in the bulk material were frequently identified in acetabular polyethylene components. Further analysis to correlated these findings with wear and performance \[[@R8]\], but while consolidating defects were found more frequently in early-retrieved cups without affecting survivorship, subsurface defects were found responsible for material loss at the articulating surface. Fourier transformed infra red (FTIR) analysis of the material from the surface to the bulk \[[@R9]\] confirmed that oxidized polyethylene was the constituent of this white band defects. Mechanical analysis of this material showed a comparatively brittle behavior with respect to non-oxidized polyethylene, as well as distinct fracture modes \[[@R10]\].

From these and other findings, it was concluded that oxidation of the polyethylene component concentrated in the subsurface in long shelf aged implants and was deleterious for the performance of the joint.

CAUSES AND AVOIDANCE OF OXIDATION IN CONVENTIONAL POLYETHYLENE
==============================================================

Oxidation of irradiated polyethylene is unavoidable as soon as the polymer is in contact with air or *in vivo* fluids. Eventually, several groups and particularly Costa *et al.* \[[@R9],[@R11]\] characterized the oxidation in failed and never implanted polyethylene components. The oxidation in never implanted components was more intense with longer times on the shelf before implantation \[[@R6],[@R7]\], and chemical studies confirmed that irradiation (gamma irradiation was the standard procedure of sterilization) in the presence of oxygen led to chain scission of the polyethylene long chain and free radical generation at the crystal surfaces \[[@R12]\]. In view of the semicrystalline structure of the material that determines many mechanical properties, any change in the microstructure may significantly alter the mechanical behavior of the material \[[@R5]\].

The oxidative degradation of the material progressed in the presence of oxygen after the irradiation process within the permeable package, while the component was sitting on the shelf. To eliminate oxygen out of the system is not an easy task, but the first reaction of the Orthopaedic community was to standardize barrier packaging to avoid oxygen permeability, and thus perform gamma irradiation sterilization either in vacuum or in the presence of inert gases (typically, nitrogen, and argon), and to recommend the avoidance of implantation 5 years after manufacture and irradiation \[[@R13]\]. Other non-penetrating sterilization methods, such as ethylene oxide or gas plasma, were reconsidered and reincorporated to the process, although ethylene oxide was originally discontinued because of the cumbersomeness of its method. Irradiation was discovered as a valuable technique not only for efficient sterilization, but also for crosslinking of the polyethylene chains.

Although the previous efforts generally succeeded in avoiding shelf aging, there has been growing evidence of the occurrence of *in vivo* oxidation of polyethylene components, not only after gamma sterilization in air, but also following gamma sterilization in nitrogen \[[@R13],[@R14]\]. Furthermore, *in vivo* oxidized polyethylene retrievals (Fig. **[3](#F3){ref-type="fig"}**) display a characteristic regional pattern, with regions protected by metal parts (bearing surface and backside) reaching lower oxidation than more exposed areas (rim) \[[@R13]-[@R16]\]. The unavoidable occurrence of *in vivo* oxidation in gamma sterilized polyethylene components stems from post-irradiation induced free radicals, which, upon oxygen availability, initiate the oxidation cycle and the associated physical changes.

NEW POLYETHYLENES TO DECREASE WEAR
==================================

The development of first-generation highly crosslinked polyethylene formulations were intended to provide medical grade UHMWPEs with an extremely high wear resistance and good oxidative stability. Thus, high doses of gamma or electron beam radiation are employed to promote an elevated crosslink density (i.e. covalent bonds) into UHMWPE, which, in turn, is responsible for a notable increase in wear resistance. In first-generation highly crosslinked polyethylenes, two different approaches were adopted to achieve oxidation resistance. First, annealing, involved a single thermal treatment below the melting temperature of UHMWPE so that crystallinity and mechanical properties were preserved \[[@R17]\]. However, the commercial highly crosslinked polyethylene obtained by gamma irradiation, annealing and finally gamma inert sterilization contained residual free radicals with the potential to oxidize *in vivo* \[[@R15]\]. The second approach was based on post-irradiation remelting of the polymer above the crystalline transition. This strategy allowed for elimination of free radicals up to undetectable levels, but at the expense of crystallinity changes and diminished mechanical properties \[[@R17], [@R18]\].

*IN VIVO* AND RETRIEVAL STUDIES ON HXLPEs
=========================================

From a wear perspective, radiographic and retrieval studies have confirmed a significantly reduced femoral head penetration for both annealed and remelted HXLPE in the first decade of implantation \[[@R19]-[@R30]\]. Table **[1](#T1){ref-type="table"}** offers a summary the significant papers. Not only clinical mid-term follow-up studies clearly show this wear rate decrease, but more precise methods such as roentgen stereogrammetry analysis (RSA) confirms this important finding in three-dimensional evaluation of cups in randomized studies (Table **[2](#T2){ref-type="table"}**).

Regarding the clinical failure modes, the revision rates of acetabular liners of both first-generation HXLPE formulations due to loosening, instability and infection remain comparable to those of conventional gamma inert sterilized liners after a decade of service \[[@R19]\]. Recent retrievals studies have confirmed that annealed highly crosslinked polyethylene acetabular liners oxidize *in vivo* (Fig. **[3](#F3){ref-type="fig"}**) and that, in some cases, exhibit damage at non-articulating areas \[[@R19],[@R30],[@R31]\]. Thus, delamination, subsurface cracking and even partial fracture of the rim have been observed under relatively unusual clinical circumstances, that is recurrent dislocations, trauma or edge loading \[[@R30]\]. Furthermore, according to a consecutive series of retrieved annealed HXLPE acetabular liners, the incidence of rim damage secondary to *in vivo* oxidation and mechanical loading appears to be as low as 5% \[[@R30]\]. Although remelted HXLPE acetabular liner retrievals exhibit near-zero oxidation levels after a decade of *in vivo* exposure, rapid crack initiation and rim fracture cases have also been reported because of the combination of decreased mechanical strength \[[@R32]-[@R34]\]. Nevertheless, the incidence of rim fracture in remelted retrievals appears to be as low as that of retrieved annealed liners \[[@R19]\]. Very recently, the hypothesized complete oxidative stability of remelted HXLPE components has been questioned in view of the increasing trend of oxidation with implantation time observed in retrievals and elevated oxidation measured after *ex vivo* aging studies \[[@R19],[@R35]\].

PRESENT AND FUTURE SOLUTIONS TO OXIDATION
=========================================

The clinical performance of first-generation HXLPE will need further research to confirm the benefits of the reduction in femoral head penetration and the clinical relevance, if any, of *in vivo* oxidation and crack initiation in the long-term, during the second decade of implantation. Currently, second-generation HXLPEs represent a promising alternative to first-generation HXLPEs as they take advantage of alternative stabilization strategies, such as natural antioxidants (vitamin E), mechanical annealing, or sequential irradiation and annealing processes \[[@R36]-[@R41]\].

In the sequentially annealed material, experimental studies proved that 4.9 mm thickness maintains a similar wear rate than thicker components, thus confirming thin components are not disadvantageous under this formulation \[[@R42]\], and support larger heads without more damage near impingement \[[@R43]\].

As for the vitamin E stabilized material, different formulations are produced either when the antioxidant is blended with the polyethylene at the time of consolidation, or if vitamin E diffuses through the consolidated polymer in the mechanism of doping. A gradient distribution of antioxidant is typically associated with the diffusion method, but polyethylene oxidation is controlled by vitamin E, as shown after 36 months of artificial aging \[[@R44]\], and the post-irradiation oxidation decreases with increasing vitamin E concentrations \[[@R45]\]. On the other hand, the vitamin E blended formulation (\< 0.1 % of vitamin E in weight) has been shown to maintain the mechanical properties of polyethylene \[[@R46]\].

Other antioxidant strategies are under development, using different free radical scavengers, such as nitroxide-TEMPO (2,2,6,6-Tetramethylpiperidine-1-oxyl) \[[@R47]\], HPAO (hindered phenol antioxidant) \[[@R48]\], or anthocyanin extracts \[[@R49]\]. Last but not least nanoscale modifications are also being studied to reinforce the polyethylene, namely composite reinforcement by multiwalled carbon nanotubes \[[@R50]\], or grafting with 2-methacryloyloxyethyl phosphorylcholine polymer \[[@R51]\] among others. Needless to say that the ongoing refinement into the polyethylene basic science and proposals will not stand until full developments are ready, and experimental and clinical data prove the concept and solidity of new polyethylene formulations. The oxidative resistance and mechanical performance of this last generation HXLPE are promising based on *in vitro* testing of the most advanced products, such as sequential annealing and vitamin E blended or diffused polyethylenes, but their impact in the clinical practice needs to be established.

![UHMWPE is a semicrystalline polymer with crystalline and amorphous regions. Crystals appear as ribbon-like lamellae and amorphous regions as gray areas in Transmission Electron Micrographs.](TOORTHJ-3-115_F1){#F1}

![After long shelf life (5 years) of a gamma irradiated in air conventional polyethylene component, a subsurface white band is clearly detected.](TOORTHJ-3-115_F2){#F2}

![After *in vivo* exposure, high oxidation areas are seen as a subsurface white band in cross-sections of a gamma air (**1**) and gamma inert (**2**) sterilized acetabular liner retrievals. Images courtesy of Professor Steven Kurtz (Implant Research Center. Drexel University. Philadelphia).](TOORTHJ-3-115_F3){#F3}

###### 

Summary of Significant Clinical Studies Confirming a Wear Rate Decrease with 1st Generation HXLPE in the Mid-Term Follow-Up

  Study                               Design and Follow-up                      HXLPE                         HEAD         Follow-Up                                        Mean Wear Rate mm/yr (After Bedding-In)   Wear Rate Decrease
  ----------------------------------- ----------------------------------------- ----------------------------- ------------ ------------------------------------------------ ----------------------------------------- --------------------
  Dorr *et al*. JBJS A 2005           Prospective, cohorts 37 hips/37           Durasul 95 kGy, remelted      28 mm CrCo   5 years                                          0.029 *vs* 0.065                          45%
  D'Antonio *et al*. CORR 2005        Retrospective, comparative 56 hips/53     Crossfire 105 KGy, annealed   28 mm CrCo   Mean 5 yr (min 4)                                0.036 *vs* 0.131                          72%
  Engh *et al*. J Arthr 2006          Prospective, randomized 208 hips          Marathon 50 kGy, remelted     28 mm CrCo   5.7 yr (4.1-7.2)                                 0.01 *vs*0.19                             95%
  Olyslaegers *et al*. J Arthr 2008   Case-control with historical 60 hips/20   Longevity 100 KGy, remelted   28 mm CrCo   XLPE 5.06 yr (52-69 mo), Std PE 5.1 yr (55-79)   0.05 *vs* 0.101                           50%
  García-Rey *et al*. J BJS-B 2008    Prospective, randomized 45 hips/45        Durasul 95 kGy, remelted      28 mm CrCo   66.3 mo (60-92)                                  0.006 *vs*0.038                           84.3%
  Geerdink *et al*. CORR 2009         Randomized, double blind 17 hips/23       Duration 30 KGy, annealed     28 mm CrCo   Mean 8yr (7-9)                                   0.088 *vs*0.142                           38%

###### 

Clinical Studies with 3D Analysis of Wear Rate with 1st Generation HXLPE

  Study                                         Design                                                 HXLPE                         Head                                         Follow-Up                  Conclusions
  --------------------------------------------- ------------------------------------------------------ ----------------------------- -------------------------------------------- -------------------------- ----------------------------------------------
  Bragdon *et al*. J Arthrop 2007 (EFORT '09)   Non-consecutive, non-randomized 30 hips                Longevity 100 kGy, remelted   28mmCrCo (16 hips) *vs* 36mmCrCo (14 hips)   3 years EFORT 09: 7-10yr   No diff 3D between 28 and 36mm
  Röhrl *et al*. Acta Orthop 2007               Retrospective, comparative 56 hips/53                  Crossfire 105 KGy, annealed   28 mm CrCo                                   XLPE 6 yr, Std 5 yr        No wear rate progression at 6yr re oxidation
  Digas *et al*. Acta Orthop 2007 (cem)         Prospective, randomized 56 hips                        Durasul 95 kGy, remelted      28 mm CrCo                                   5 years                    0.001 *vs* 0.06mm/yr (3D) (98% decrease)
  Digas *et al*. Acta Orthop 2007 (hybr)        Prospective, randomized contralat control 32 hips/32   Longevity 100 KGy, remelted   28 mm CrCo                                   5 years                    0.00 *vs* 0.057mm/yr(3D) (99-100% decrease)
  Glyn-Jones *et al*. J Arthrop 2008            Prospective, doub-blind, rand, controlled 26 hips/25   Longevity 100 KGy, remelted   28 mm CrCo                                   2 years                    0.06 mm/yr *vs* 0.10 (3D) (40% decrease)
